rs784888

Variant names:

• chr12-53430724-G-A
• rs784888
• ENST00000552233.5:n.1622G>A

Your query was ambiguous. Multiple possible variants found:

• chr12-53430724-G-A
• chr12-53430724-G-C
• chr12-53430724-G-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2 BP4_Strong

The ENST00000552233.5(AMHR2):​n.1622G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency:
  • Genomes: not found (cov: 32)
  • Exomes 𝑓: 0.0 (0 hom.)
  • Failed GnomAD Quality Control
• Consequence: AMHR2 ENST00000552233.5 non_coding_transcript_exon
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 2.30
• Publications: 9 publications found

Genes affected

AMHR2 (HGNC:465): (anti-Mullerian hormone receptor type 2) This gene encodes the receptor for the anti-Mullerian hormone (AMH) which, in addition to testosterone, results in male sex differentiation. AMH and testosterone are produced in the testes by different cells and have different effects. Testosterone promotes the development of male genitalia while the binding of AMH to the encoded receptor prevents the development of the mullerian ducts into uterus and Fallopian tubes. Mutations in this gene are associated with persistent Mullerian duct syndrome type II. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Sep 2009]

AMHR2 Gene-Disease associations (from GenCC):

• persistent Mullerian duct syndrome

  Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

ACMG classification

Our verdict: Likely_benign. The variant received -2 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.57).

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
AMHR2	NM_020547.3	c.1425+442G>A		intron_variant	Intron 10 of 10	ENST00000257863.9	NP_065434.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
AMHR2	ENST00000552233.5	n.1622G>A		non_coding_transcript_exon_variant	Exon 4 of 4	1
AMHR2	ENST00000257863.9	c.1425+442G>A		intron_variant	Intron 10 of 10	1	NM_020547.3	ENSP00000257863.3
AMHR2	ENST00000379791.7	c.1141-453G>A		intron_variant	Intron 8 of 8	1		ENSP00000369117.3
AMHR2	ENST00000550311.5	c.1421+442G>A		intron_variant	Intron 10 of 10	1		ENSP00000446661.1

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0 AN: 196186 Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0 AN XY: 104312

African (AFR) AF: 0.00 AC: 0 AN: 6210

American (AMR) AF: 0.00 AC: 0 AN: 8728

Ashkenazi Jewish (ASJ) AF: 0.00 AC: 0 AN: 5264

East Asian (EAS) AF: 0.00 AC: 0 AN: 9256

South Asian (SAS) AF: 0.00 AC: 0 AN: 30948

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 9446

Middle Eastern (MID) AF: 0.00 AC: 0 AN: 758

European-Non Finnish (NFE) AF: 0.00 AC: 0 AN: 115346

Other (OTH) AF: 0.00 AC: 0 AN: 10230

GnomAD4 genome Cov.: 32

Alfa AF: 0.00 Hom.: 43

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.57
CADD	Benign	8.9
DANN	Benign	0.85
PhyloP100		2.3

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs784888; hg19: chr12-53824508;